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There is growing evidence that oxidative stress plays an integral role in the processes by
which obesity causes type 2 diabetes. We previously identified that mice lacking the protein
oxidation repair enzyme methionine sulfoxide reductase A (MsrA) are particularly prone to
obesity-induced insulin resistance suggesting an unrecognized role for this protein in meta-
bolic regulation. The goals of this study were to test whether increasing the expression of
MsrA in mice can protect against obesity-induced metabolic dysfunction and to elucidate
the potential underlying mechanisms. Mice with increased levels of MsrA in the mitochon-
dria (TgMito MsrA) or in the cytosol (TgCyto MsrA) were fed a high fat/high sugar diet and
parameters of glucose homeostasis were monitored. Mitochondrial content, markers of
mitochondrial proteostasis and mitochondrial energy utilization were assessed. TgMito
MsrA, but not TgCyto MsrA, mice remain insulin sensitive after high fat feeding, though
these mice are not protected from obesity. This metabolically healthy obese phenotype of
TgMito MsrA mice is not associated with changes in mitochondrial number or biogenesis or
with a reduction of proteostatic stress in the mitochondria. However, our data suggest that
increased mitochondrial MsrA can alter metabolic homeostasis under diet-induced obesity
by activating AMPK signaling, thereby defining a potential mechanism by which this genetic
alteration can prevent insulin resistance without affecting obesity. Our data suggest that
identification of targets that maintain and regulate the integrity of the mitochondrial prote-
ome, particular against oxidative damage, may play essential roles in the protection against
metabolic disease.
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Introduction
Environmental factors, such as obesity, and genetic factors are both causative for the underly-
ing pathophysiology of T2DM, particularly in the development of hyperglycemia and insulin
resistance. However, there remains only a vague understanding of the basic mechanisms
through which these factors promote such metabolic dysfunctions. There is growing evidence
from clinical and basic research suggesting that oxidative stress plays a defining role in this pro-
cess and it is now well-recognized that there is an association between elevated levels of oxida-
tive stress and damage in vivo and the clinical assessment of T2DM [1–3]. Moreover, markers
of oxidative stress have been reported to increase even in those with pre-diabetes, suggesting that
an elevation of oxidative stress precedes the clinical diagnosis of diabetes [3]. In mice, genetic or
pharmaceutical reduction of oxidative stress has been shown to be sufficient to reduce the sever-
ity of, or even prevent, hyperglycemia and insulin resistance caused by high fat feeding [4–7].
While these results point to a likely role for oxidative stress in the pre-clinical stages of T2DM,
the use of broad-range antioxidants has limited clinical benefits in treating T2DM or many of its
complications [8]. One possible interpretation of this lack of effect may be that the cellular oxida-
tive damage caused by oxidative stress prior to the diagnosis of T2DMmay drive the diminished
metabolic response associated with obesity. Because antioxidants simply alleviate oxidative stress,
perhaps identifying ways to repair or remove this damage may then have therapeutic benefits for
metabolic disease that haven’t been realized using current approaches.
The protein oxidation repair enzyme methionine sulfoxide reductase A (MsrA) has been
linked with the development of metabolic dysfunction both correlatively and causatively. MsrA
is one of two mammalian methionine sulfoxide reductase isoforms that play a critical role in
maintaining the proteome in a relatively reduced state by catalytically repairing oxidized resi-
dues of the essential amino acid methionine [9]. The sulfur-containing side chain of methio-
nine is extremely sensitive to oxidation which can directly and detrimentally alter the
conformation of many proteins due to the change in hydrophobicity that occurs during methi-
onine oxidation [10]. Interestingly, multiple genome-wide association studies (GWAS) have
identified single nucleotide polymorphisms within a genetic loci containing the human MSRA
gene that are associated with central adiposity and BMI, changes in fat distribution, and meta-
bolic syndrome in studies of multiple different populations [11–14]. In addition, both genetic
and diet-induced obesity in rats promotes a significant reduction of MsrA activity in visceral
adipose tissue [15]. However, until recently, it remained unclear whether these association
were driven by a direct anti-diabetogenic role for MsrA. We recently showed that the lack of
MsrA in mice (MsrA KO) directly impairs the regulation of glucose metabolism in that MsrA
KOmice are strikingly more susceptible to high fat diet-induced insulin resistance, at least in
part by regulating accumulation of oxidative damage [16].
Given these findings, we hypothesized that an increase in MsrA may be beneficial to glucose
metabolism and protect against the metabolic dysfunctions caused by obesity. Normally,
approximately 75% of total cellular mammalian MsrA is targeted to the cytosol and the
remaining 25% to the mitochondria with both pools originating from a single MsrA gene that
undergoes alternative translation [17, 18]. To dissect the role of the isoforms of MsrA in this
study, we utilized two transgenic mouse models generated to overexpress levels of MsrA in dif-
ferent sub-cellular compartments. One mouse model targets this increased MsrA expression
preferentially to the mitochondria (TgMito MsrA) and the second targets MsrA preferentially
to the cytosol (TgCyto MsrA) [19, 20]. In this study, we identified that mitochondrial MsrA
protects against obesity-induced metabolic dysfunction, further highlighting the importance of
mitochondria in the regulation of glucose metabolism under metabolic stress and identifying a
novel role for MsrA in this process.
Mitochondria MsrA Prevents Insulin Resistance in Mice
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Methods
Animals
All procedures involving mice were approved by the Subcommittee for Animal Studies at the
Audie L. Murphy Veterans Administration Hospital at San Antonio and the Institutional Ani-
mal Care and Use Committee at the University of Texas Health Science Center at San Antonio.
TgMito MsrA mice used in this study were previously identified as TgMito_MsrAMTS and
mitochondrial-targeting of overexpressed transgene was accomplished utilizing the preferential
translation from the native mitochondrial targeting sequence [20]. TgCyto MsrA mice in this
study were previously identified as TgCyto_Myr and cytosolic-targeting of overexpressed
transgene was accomplished by deletion of the mitochondrial targeting sequence [20]. The
maintenance and characterization of MsrA knockout mice (MsrA KO) have been previously
described [16]. TgMito X MsrA KO mice were generated by targeted breeding of MsrA KO
and TgMito MsrA mice. All strains of mice have been maintained in the C57BL/6J genetic
background. Mice were genotyped for presence of transgene (or neo cassette in the case of
MsrA KO) and overexpression/knockout was confirmed by immunoblot. Mice were main-
tained at a density of 3–4 mice/cage. For feeding and insulin resistance studies, male mice were
used after reaching adulthood (between 6–8 months of age).
High fat/high sugar diets
All high fat/high sugar (hereafter abbreviated HFD) studies utilized male mice and diet studies
were initiated at approximately 6–8 months of age. Prior to dietary studies, mice were main-
tained on a standard NIH-31 chow diet (Harlan Teklad, Madison, WI, USA) provided ad libi-
tum. Control-fed mice in this study were maintained on this standard chow throughout. For
HFD studies, male mice at 6–8 months were fed a commercially available, defined diet contain-
ing 45% kcal from fat the source of which was primarily lard (58V8, TestDiet, St. Louis MO).
Both chow and HFD were provided ad libitum and food consumption and body weight were
monitored biweekly. Mice were fed HFD for a total period of 13 weeks; at 12 weeks a glucose
tolerance test was performed and at 13 weeks an insulin tolerance test was performed (methods
described below). Mice were sacrificed during week 13 of HFD feeding.
Insulin tolerance tests and blood chemistry
For insulin tolerance tests, mice were fasted for 6 hours during the light cycle (09:00–15:00)
prior to intraperitoneal (ip) injection of 1U of insulin (Novalin R; Novo Nordisk, Princeton,
NJ, USA) per kilogram of body weight. Blood glucose was measured at indicated time points
after injection by ONE Touch Ultra handheld glucometer. For measurements of metabolites,
blood plasma was collected at sacrifice of mice fasted overnight (18:00–09:00) and measure-
ments of insulin (Crystal Chem, Downer’s Grove, IL), adiponectin (EMDMillipore, Billerica,
MA), and leptin (EMDMillipore) were performed by ELISA following manufacturer’s instruc-
tions. HOMA-IR were calculated using HOMA2 calculator available from University of
Oxford.
Subcellular fractionization and immunoblots
Subcellular fractionations were performed by enrichment centrifugation of samples isolated
from freshly collected whole hind-limb skeletal muscle. We used a modified method of mito-
chondrial isolation previously described [21]. After excision, tissues were minced and homoge-
nized in Chappell-Perry buffer I [100 mM KCl, 50 mM 3-propanesulfonic acid (MOPS), 1mM
ethylenediaminetetraacetic acid (EDTA), 5mMMgSO4, 1mM ATP, pH 7.4] with the protease
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nagarse then centrifuged 10 minutes at 1,000 x g. A portion of the supernatant (1,000s) was
retained for assessment of total cellular MsrA content and the remainder passed through
cheesecloth and centrifuged at 10,000 x g for 10 minutes. The final pellet containing the mito-
chondrial fraction (10,000p) and the supernatant containing cytosolic components (10,000s)
were collected; the (10,000p) fraction was solubilized in Chappell-Perry buffer I containing 1%
Tween-20 and protease inhibitors in preparation for immunoblot. For all other immunoblots,
total protein extracts were isolated from liver, skeletal muscle (gastrocnemius) and visceral fat
(epigonadal depot) tissue that had been snap frozen in liquid nitrogen after mouse sacrifice
and stored at -80°C until use. Prior to sacrifice, mice had either been (1) fasted overnight and
given an ip injection of insulin (1U/kg body wt) or (2) fasted overnight and given an ip injec-
tion of saline. Mice were then sacrificed 15 minutes after injection. Protein extracts were
homogenized in RIPA buffer with additional protease and phosphatase inhibitors (Thermo
Scientific, Rockford, IL, USA), centrifuged at 14,000g at 4°C for 15 minutes, and then stored at
-80°C until needed. Equal amounts of protein samples were separated electrophoretically by
SDS-PAGE and then transferred to polyvinylidene difluoride membrane (Millipore, Billerica,
MA, USA). Primary antibodies and their sources used in this study: MsrA, GAPDH, mitochon-
drial complex I subunit 20 (CI-20), LonP, HtrA2, Hsp60, Grp75, Mitosciences OxPhos Cock-
tail (Abcam, Cambridge MA) and phosphor-Akt (Ser473), phospho-GSK-3α Ser21), Akt,
GSK-3α, phospho-ACC (Ser79), ACC, phospho-AMPKβ1 (Ser108) and AMPKβ1/2 (Cell Sig-
naling, Beverly MA). All alkaline phosphatase-conjugated secondary antibodies (anti-rabbit
and anti-mouse) were purchased through Santa Cruz Biotechnologies (Santa Cruz, CA, USA).
Protein bands on immunoblots were detected using ECL reagent (Thermo Scientific) and ana-
lyzed using ImageJ.
Citrate synthase activity
Citrate synthase catalyzes the reaction of Acetyl CoA and oxaloacetate to form citrate and
CoA-SH. Tissue homogenates prepared in RIPA buffer were assayed in Triethanolamine-HCl-
buffer (pH 8.0) containing Acetyl-CoA, oxaloacetic acid, and DTNB [5,5'-dithiobis-(2-nitro-
benzoic acid] (Sigma-Aldrich, St. Louis MO) to assay citrate synthase activity in a 96 well plate.
To account for background reactions, an initial reaction performed in the absence of oxaloace-
tic acid was performed and subtracted from the final values of the reactions containing oxalo-
acetic acid. The CoA-SH reacts with DTNB to produce the yellow color which can be
measured at 412 nm with kinetic reading on Spectra Max plate reader with the rate of color
development being proportional to citrate synthase activity. The data was normalized by the
amount of protein used during the assay and presented as nanomole per milligram protein per
minute.
Statistical analyses
Data were analyzed by one way or two way ANOVA with post-hoc analysis by Holm-Sidak or
by Student’s t-test where appropriate. Data reaching p< 0.05 (with adjustment for multiple
comparison) were considered statistically significant.
Results
Mitochondrial, but not cytosolic, MsrA overexpression prevents obesity-
induced insulin resistance
In adult male mice maintained on standard rodent chow (SD), body weights of both transgenic
lines did not differ from control (WT) mice (Fig 1). When fed HFD, both TgCyto and TgMito
Mitochondria MsrA Prevents Insulin Resistance in Mice
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lines gained weight on a similar trajectory as WT mice and after 12 weeks of feeding we found
no significant difference among the three lines (Fig 1). At sacrifice, HFD-fed WT and TgMito
Fig 1. Overexpression of MsrA in the mitochondria prevents obesity-induced insulin resistance without altering weight gain. (A) Body weights of
WT (n = 26), TgMito MsrA (n = 19), and TgCyto MsrA (n = 12) mice fed standard rodent chow (SD) or high fat diet (HFD). Bars represent mean body
weight ± SEM. (B) Body weight gain of mice in (A) with HFD feeding. (C) Glucose tolerance tests of WT (n = 22), TgMito MsrA (n = 13), and TgCyto MsrA
(n = 7) maintained on standard rodent chow (SD) or high fat diet (HFD). Circles represent mean body weight ± SEM.
doi:10.1371/journal.pone.0139844.g001
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mice did not differ in fat distribution as measured by the weights of each individual fat depot,
but TgCyto subcutaneous and brown fat depots were slightly, though significantly, larger than
both (Table 1).
HFD-feeding caused glucose intolerance among all three genotypes of mice; however, there
was no effect of genotype on glucose tolerance in mice fed either SD or HFD (Fig 1). Similarly,
there was no difference in insulin response as measured by insulin tolerance tests among the
three lines when mice were maintained on a low-fat SD (Fig 2). Mice fed a HFD showed
reduced insulin sensitivity compared to their SD-fed counterparts (Fig 2). TgCyto MsrA and
WTmice did not differ in the degree of insulin resistance caused by HFD feeding. In contrast,
TgMito MsrA mice were significantly more insulin sensitive than both WT and TgCyto MsrA
mice after HFD feeding, though still relatively insulin resistant compared to mice maintained
on a SD (Fig 2). Fasting (6 hour) plasma glucose concentrations did not differ among the three
genotypes of HFD-fed mice (WT fasting glucose (± SEM) = 174 ± 5 mg/dL, TgMito
MsrA = 164 ± 5 mg/dL, TgCyto = 189 ± 11 mg/dL). However, fasting (6 hour) insulin concen-
trations were significantly reduced in HFD-fed TgMito MsrA mice compared to both HFD-fed
WT and TgCyto MsrA mice suggesting reduced need for insulin to maintain relative normal
glucose levels (Fig 2). HFD-fed TgMito MsrA mice also showed a reduction in HOMA-IR
index, indicative of the relative insulin sensitivity in this group of mice compared to the other
two genotypes (Fig 2). The metabolic benefit of TgMito MsrA mice among HFD-fed mice was
not associated with significant alterations in concentrations of leptin, adiponectin or triglycer-
ides in the plasma measured after an overnight fast (Fig 2).
Because TgMito MsrA mice still maintain endogenous MsrA expression in both the cytosol
and mitochondria, we next tested whether mitochondrial MsrA overexpression even in the
absence of cytosolic MsrA could prevent HFD-induced metabolic dysfunction. To address this,
we crossed TgMito MsrA mice to mice lacking MsrA (MsrA KO) to generate a line of mice car-
rying the mitochondrial-targeted MsrA transgene in an MsrA-null background (TgMito X
KO). After feeding a HFD, we found that both TgMito MsrA and TgMito X KOmice remained
relatively more insulin sensitive compared to MsrA KOmice (Fig 3). Moreover, we found no
evidence for any difference in insulin sensitivity between TgMito MsrA and TgMito X KO
lines of mice. These results suggest that the metabolically beneficial phenotype of TgMito
MsrA mice is due solely to the mitochondrial overexpression of MsrA and not to any potential
interaction with the endogenous cytosolic MsrA.
Several tissues, including muscle, liver and adipose tissue, contribute to the regulation of
glucose concentrations in response to insulin by activation of insulin signaling to promote glu-
cose uptake. After HFD-feeding, insulin-stimulated activation (phosphorylation) of Akt and
GSK-3α in was significantly reduced in muscle to SD-fed mice (S2 Fig). In line with our insulin
Table 1. Weight (±SE) of adipose tissue depots in HFD fedmice.
Adipose depot WT (g) TgMito MsrA (g) TgCyto MsrA (g)
Epigonadal 2.23 (0.08) 2.16 (0.11) 2.31 (0.12)
Perirenal 1.16 (0.08) 1.16 (0.15) 1.31 (0.16)
Mesenteric 0.89 (0.11) 0.87 (0.15) 0.61 (0.18)
Inguinal subcutan. 1.38 (0.09)a,b 1.02 (0.13)a 1.65 (0.12)b
Subscapular subcutan. 0.71 (0.05) 0.68 (0.05) 0.74 (0.07)
Brown 0.27 (0.02)a 0.24 (0.03)a 0.37 (0.02)b
Numbers highlighted in bold represent p < 0.05 as determined by ANOVA. Values indicated by highlighted
letters (a or b) indicate groups that do not differ statistically as analyzed post-hoc.
doi:10.1371/journal.pone.0139844.t001
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tolerance test data, insulin-stimulated phosphorylation of Akt and GSK-3α was relatively high
in gastrocnemius muscle from HFD-fed TgMito MsrA mice as compared to HFD-fed WT sug-
gesting a relative preservation of insulin signaling in this tissue (Fig 3). Surprisingly, visceral
adipose (epigonadal depot) and liver showed no difference in these markers at the resolution of
this assay suggesting that increased mitochondrial MsrA may not prevent HFD-induced insu-
lin resistance in these tissues (Fig 3). This might partly be due to the relatively higher mito-
chondrial content of muscle relative to liver and fat. Based on these findings, we focused the
remainder of our study on skeletal muscle. Among SD-fed mice, there was no difference in
insulin activation in this tissue (S1 Fig), suggesting that the overexpression of mitochondrial
MsrA helps to prevent insulin resistance caused by metabolic stress, rather than generally
improving insulin signaling under all conditions.
Fig 2. Mitochondrial MsrA overexpression prevents insulin resistance and hyperinsulinemia caused by obesity. (A) Insulin tolerance tests of WT
(n = 22), TgMito MsrA (n = 13), and TgCyto MsrA (n = 7) mice maintained on standard rodent chow (SD) or high fat diet (HFD). All values for each genotype
are normalized to the fasting blood glucose level of that genotype prior to injection of insulin. Asterisks represent p<0.05 by one-way ANOVA. (B) Area under
curve (AUC) calculated for Insulin tolerance tests in Fig 1. Bars represent mean AUC x SEM. (C) Fasting (6 hour) plasma insulin concentration and HOMA-IR
(normalized to meanWT value) of indicated mice maintained on high fat diet. (D) Relative plasma concentrations of leptin (Lep), adiponectin (Adip), and
triglycerides (TAG) from overnight fasted, high fat diet-fed animals (values normalized to meanWT levels for each). Bars represent mean values ± SEM. For
all, asterisks represent p<0.05 by one-way ANOVA.
doi:10.1371/journal.pone.0139844.g002
Mitochondria MsrA Prevents Insulin Resistance in Mice
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Overexpression of mitochondrial MsrA does not alter mitochondrial
content but activates AMPK signaling in obese mice
While endogenous MsrA is expressed in at relatively low levels in skeletal muscle [16], expres-
sion of MsrA is approximately 10–40 fold higher in muscle from both transgenic lines with
overall expression of MsrA in the TgMito MsrA line greater than that found in mice of the
TgCyto MsrA line (Fig 4A). Previous reports have suggested a similar level of overexpression
in liver, heart, and fibroblasts derived from these lines of mice as well as relative increases in
MsrA activity [19, 20]. We confirmed that the increased expression of MsrA in muscle of each
line was targeted correctly to the intended cellular localization, i.e., increased MsrA was tar-
geted to the mitochondria in TgMito MsrA mice and to the cytosol in TgCyto MsrA mice (Fig
4). Because TgMito MsrA mice were generated using the endogenous MsrA mitochondrial tar-
geting sequence, it is likely that MsrA produced from the transgene is localized in its native
location in the mitochondrial matrix [18–20, 22]. We first considered that increased MsrA
may reduce levels of obesity-induced oxidative stress. As predicted, mice fed HFD showed an
increase in oxidation of proteins (carbonyls) in skeletal muscle; however, carbonyls were not
reduced in HFD-fed TgMito MsrA mice suggesting that this was not the likely mechanism for
Fig 3. Increased MsrA in the mitochondria prevents insulin resistance even in the absence of cytosolic MsrA. (A) Insulin tolerance tests for HFD-fed
MsrA KO (n = 6), TgMito MsrA (n = 4), and TgMito MsrA X KO (n = 7) mice. Circles represent mean blood glucose ± SEM. All values for each genotype are
normalized to the fasting blood glucose level of that genotype prior to injection of insulin. (B) Area under curve (AUC) calculated for data in (A). Asterisks
represent p<0.05 by one-way ANOVA (C) Representative blot of phosphorylation of Akt (Ser473) and GSK-3α (Ser21) in muscle (gastrocnemius) from HFD-
fed mice. (D) Quantitation of phosphorylation of Akt and GSK-3α in muscle (gastrocnemius), visceral white adipose tissue (epigonadal) and liver. Values are
normalized relative to meanWT value. Asterisks represent p<0.05 between genotypes by Student’s t-test. For all, bars represent mean AUC ± SEM.
doi:10.1371/journal.pone.0139844.g003
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preserved insulin sensitivity in these mice (S1 Supporting Information and S2 Fig). We next
considered that increasing MsrA in the mitochondria might promote mitochondrial biogene-
sis, but found that genotype had no effect on the activity of citrate synthase, a reliable estimate
of relative mitochondria quantity, in the muscle of either SD- or HFD-fed (Fig 4). However,
citrate synthase activity was significantly reduced (p = 0. 026) in muscle from HFD-fed mice
relative to tissue collected from mice on SD. We also found that genotype did not alter relative
expression levels of of subunits of electron transport chain complexes I-V on either SD or HFD
(Fig 4). Prolonged feeding with HFD did significantly reduce expression of complex IV
(p = 0.042) and increase expression of complex V (p = 0.002) relative to SD among all mouse
strains.
Because MsrA plays a primary role in protein oxidation repair, we addressed whether there
was evidence that increasing mitochondrial MsrA might alleviate mitochondrial proteostatic
stress. Obesity/HFD is associated with higher levels of oxidative damage, including damage to
Fig 4. Overexpression of mitochondrial MsrA does not alter mitochondrial content. (A) Representative blot of MsrA expression in muscle. (B)
Representative blot of subcellular distribution of MsrA in muscle. (1,000s) = 1,000 x g supernatant, 10,000s = 10,000 x g supernatant, 10,000p = 10,000 x g
pellet. (C) Citrate synthase activity in muscle from SD- and HFD-fed mice. Asterisks and horizontal line indicate significant effect of diet as measured by two
way ANOVA. (D) Quantification of western blots for Complex I subunit NDUFB8 (Complex I), Complex II subunit 30kDa (Complex II), Complex III subunit
Core 2 (Complex III), Complex IV subunit I (Complex IV), and ATP synthase subunit alpha (Complex V). Values are given as arbitrary units (AU) normalized
among groups to levels of VDAC. Bars represent mean (relative to values in WT) ± SEM. Asterisks and horizontal line indicate significant effect of diet as
measured by two way ANOVA.
doi:10.1371/journal.pone.0139844.g004
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proteins [1–7]. Oxidized proteins can initiate the unfolded protein response (UPR), a cellular
response to alleviate proteostatic stress. The mitochondria maintain an organelle-specific net-
work (mitochondrial UPR) to regulate protein quality control [23]. We tested whether the
improved insulin sensitivity of HFD-fed TgMito MsrA mice might be associated with modula-
tion of this network by measuring levels of several of these components in muscle. These com-
ponents included the ATP-dependent mitochondrial proteases Lon protease and ClpP; the
serine protease HtrA2/Omi, and the mitochondrial protein chaperones Grp75, Hsp60. With
the exception of modestly increased levels of HtrA2/Omi in TgMito MsrA muscle, there was
little effect of mitochondrial MsrA on expression of mitochondrial UPR components in HFD-
fed mice (Fig 5).
We next tested whether overexpression of MsrA in the mitochondria might alter metabolic
homeostasis that then improves insulin sensitivity under metabolic stress [24]. AMP-activated
protein kinase (AMPK) is a cellular energy sensor that can up-regulate fatty acid oxidation in
response to low levels of cellular ATP. We found evidence for increased activation of this path-
way in muscle from HFD-fed MitoTg MsrA mice with increased phosphorylation of both the
AMPKβ1 subunit, and a key downstream target of AMPK, Acetyl-CoA carboxylase (ACC),
and upregulation (though not statistically significant) of the transcriptional regulator PPARγ
coactivator-1 (PGC1) (Fig 6). Together, these data suggest that activation of this pathway in
TgMito MsrA may at least in part mediate the improved insulin sensitivity of these mice under
obese, HFD-fed conditions.
Discussion
In this study, we show that increasing levels of the protein repair enzyme MsrA in the mito-
chondria, but not cytosol, improves metabolic dysfunction in mice rendered obese by feeding a
high fat/high sugar diet. Both the cytosolic and mitochondrial forms of MsrA are translated
from a single MsrA gene encoding 233 residues. Translation beginning from residue 1 of this
gene encodes a mitochondrial targeting sequence whereas translation from residue 21 skips
this targeting sequence and results in cytosolic MsrA [17]. Both the cytosolic and mitochon-
drial form of MsrA are equally capable of reducing methionine sulfoxide in vitro [17, 19].
Fig 5. Mitochondrial-targeted MsrA overexpression does not alter expression of mitochondrial unfolded protein response in muscle from HFD-fed
mice. (A) Representative blots for indicated proteins. Complex I subunit NDUFB8 (CI-20) was used as a loading control. (B). Quantification of (A). Bars
represent mean (relative to mean values in WT) ± SEM. Asterisks represent p<0.05 between genotypes by Student’s t-test.
doi:10.1371/journal.pone.0139844.g005
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Together with our previous study [16], we have now clearly identified a significant and novel
role of MsrA, particularly in the mitochondria, in the regulation of glucose metabolism and
insulin response in mice. Further examination of the benefits of mitochondrial MsrA against
metabolic stress may be able to more accurately define these potential mechanisms.
While the finding that mitochondrial-targeted MsrA is intriguing, it is also counter to our
initial prediction that cytosolic MsrA may be more beneficial. First, the normal distribution of
MsrA in the mammalian cell is approximately three times greater in the cytosol than in the
mitochondria [17, 18], suggesting the potential for a greater cytosolic need for this antioxidant
repair enzyme. Second, we previously highlighted a role for MsrA in preserving cellular insulin
response by preventing the accumulation of oxidative adducts on the insulin receptor, a trans-
membrane protein that partially exists within the cytosol [16]. The lack of the repair of these
adducts in MsrA KOmice contributes to their sensitivity to obesity-induced insulin resistance.
However, our findings here show that replacing MsrA at high levels in the mitochondria alone
abolishes the increased susceptibility to insulin resistance of MsrA KOmice. While we did not
formally measure the oxidation of insulin receptor in this study, it seems unlikely that overex-
pression of MsrA in the mitochondria could directly modulate the oxidation repair of a protein
found at the cellular membrane. Because the activity of MsrA is regulated primarily through
the activity of thioredoxins, however, we cannot exclude the possibility that alterations in the
redox environment of the mitochondria could not directly alter those in the cytosol. Thus,
these data point to at least two different ways in which MsrA likely plays a role in the regulation
of glucose homeostasis. Our results here do present a potential confound as the total expression
level of MsrA is higher in the muscle of TgMito MsrA mice than it is in TgCyto MsrA mice. It
is possible that our findings result from the higher levels of MsrA rather than its cellular loca-
tion and this idea warrants further exploration.
Mitochondrial dysfunction and/or insufficiency has been speculated to be an underlying
cause of the numerous metabolic dysfunctions that develop due to obesity [25, 26]. While
MsrA is ubiquitously expressed both natively and in these transgenic mice, we found that pro-
tective benefit of mitochondrial MsrA overexpression may be primarily due to its effects in
skeletal muscle. Because skeletal muscle has a fundamental role in the maintenance of normal
glucose homeostasis, profound reductions in respiratory capacity, mitochondrial number, and
impaired utilization of substrates of mitochondria in this tissue have been linked with obesity,
Fig 6. Increasedmitochondrial MsrA promotes increased AMPK signaling in mice fed a high fat diet. (A) Representative blot assessing
phosphorylation of ACC and AMPK and expression of PGC1α in muscle from HFD-fed mice. (B) Quantification of A. Bars represent mean (relative to mean
values in WT) ± SEM. Asterisks represent p<0.05 between genotype by Student’s t-test.
doi:10.1371/journal.pone.0139844.g006
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insulin resistance, and T2DM [27, 28]. Intriguingly, the early transition to HFD has been associ-
ated with an increase in mitochondrial number and a shift towards preferential fatty acid oxida-
tion capacity suggesting a potential compensatory response [29, 30]. However, chronic exposure
to high levels of fatty acids, as would occur with the consumption of a HFD, disrupts mitochon-
drial fuel utilization and can result in incomplete β-oxidation of fatty acids and depletion of
mitochondrial substrate intermediates [31]. We did find evidence that increased levels of mito-
chondrial MsrA were associated with elevated activation of the AMPK pathway. Activation of this
pathway has been shown elsewhere to promote mitochondrial fatty acid oxidation [24, 32]. Fur-
ther studies will be required to address the potential role mitochondrial MsrA in this pathway.
The normal function of MsrA in the mitochondria is still a matter of debate. While no direct
role for MsrA has yet been noted in the regulation of mitochondrial energetic function, the lack
of this enzyme in yeast and mammalian cells produces various different forms of mitochondrial
dysfunction [33, 34]. In the mitochondria, MsrA can directly interact with the ETC complexes in
vivo and prevents oxidation and aggregation of the ETC-associated protein cytochrome C follow-
ing treatment with oxidative stress [35]. Similarly, the lack of MsrA in mice has been associated
with increased oxidation of the cardiac mitochondrial proteome [36]. Intriguingly, the mitochon-
drial proteome is relatively rich in methionine residues compared to the cytosolic proteome, sug-
gesting these proteins are at greater risk for methionine oxidative damage [37]. Moreover, the
import of most mitochondrial proteins from the cytosol occurs in an unfolded state that is highly
susceptible to oxidation [38]. It is interesting to note that MsrA preferentially repairs oxidized
methionines in unfolded proteins, suggesting MsrA has a chaperone-like role in maintaining pro-
teostasis [39]. While we did not find strong evidence that mitochondrial MsrA dramatically alters
the mitochondrial UPR, a careful address of how obesity and mitochondrial MsrA affect the oxi-
dation of the mitochondrial proteome could enlighten this field.
Part of our rationale for this study was based on reported associations between single nucle-
otide polymorphisms within a chromosome region containing the human MSRA loci and the
incidence of obesity and metabolic syndrome in human populations [11–14]. In support,
plasma levels of methionine sulfoxide are relatively increased in patients diagnosed with diabe-
tes [40, 41]. However, a significant question that remains regarding the biological rationale for
these relationships. One possibility could be that oxidation of methionine residues, and their
subsequent reduction by MsrA, acts as a free-radical sink to reduce the potential for damaging
other, potentially more critical, amino acid residues in cellular proteins as has been proposed
by Levine et al. [42, 43]. The association between MsrA and insulin resistance might simply
reflect alterations in the cells ability to utilize this “last-chance” antioxidant defense system for
proteins. Our results suggest that reducing the oxidative stress and subsequent protein oxida-
tive damage in the mitochondria, and not the cytosol, may play a critical role in preventing
obesity-induced metabolic disease, as has been previously reported [4, 7].
On the other hand, the reversibility of methionine oxidation through methionine sulfoxide
reductases suggests its potential as a cellular regulatory moiety akin to phosphorylation or acet-
ylation. The oxidation of a single methionine residue to methionine sulfoxide in a voltage-
gated potassium channel inactivates the function of this channel [44]. Moreover, expression of
MsrA sufficiently reduces this methionine sulfoxide and re-activates the potassium channel.
The activity of a key mitochondrial regulatory protein, calcium/calmodulin-dependent protein
kinase II (CAMKII), is also regulated by methionine oxidation [36]. CAMKII regulates the
mitochondrial calcium uniporter which controls the Ca2+ uptake and sequestration that are
critical for regulating ATP production through the citric acid cycle [45]. Oxidation of CAMKII
at key methionine residues activates this protein and interferes with the interaction of the auto-
inhibitory and catalytic domains; activation is ablated by replacing these methionine residues
with valines [36]. CAMKII oxidation is significantly increased in the hearts of MsrA KOmice
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and leads to increased apoptosis and reduced survival following myocardial infarct surgery
[36]. Diabetes is also associated with increased oxidation of CAMKII and transgenic mice gen-
erated with a methionine oxidation resistant CAMKII are able to maintain normal cardiac
function even with diabetes [46]. What role CAMKII may play in the development of skeletal
muscle insulin resistance remains to be addressed; however, CAMKII has been implicated in
mediating the effects of ER stress, which itself has been linked as a driver of insulin resistance
[47, 48]. Interestingly, MsrA has been shown to have the ability to both catalytically reduce as
well as catalytically oxidize methionine through a reversal of the reduction process [49]. This
raises the intriguing possibility that the activation/inactivation of proteins such as CAMKII
may be directly regulated by MsrA rather than mediated through passive oxidation processes.
Identifying mechanisms by which some of those clinically classified as obese remain meta-
bolically healthy could provide targets for therapeutic approaches to benefit those at-risk for
metabolic diseases. Increasing mitochondrial MsrA recapitulates some of these phenotypes in
that the mice are obese but remain insulin sensitive. While previous studies have largely shown
limited effects of antioxidant therapy in diabetes, development of antioxidants targeted specifi-
cally to the mitochondria have shown promise in rodent models [4, 7]. Moreover, because
MsrA is capable of repairing a particular form of oxidative damage, using this model might be
capable of identifying specific proteins and/or residues to which these strategies could be tar-
geted. Such therapeutic approaches could then bring about the promise of reversing the effects
of T2DM or other metabolic disorders rather than simply addressing their symptoms.
Supporting Information
S1 Fig. Overexpression of MsrA does not alter insulin signaling in muscle from chow-fed
mice. (A) Representative blot of phosphorylation of Akt (Ser473) and GSK-3α (Ser21) in mus-
cle (gastrocnemius) from SD- and HFD-fed mice. Mito = TgMito, Cyto = TgCyto. (B) Quanti-
tation of phosphorylation of Akt and GSK-3α in muscle (gastrocnemius) from SD-fed WT,
TgMito and TgCyto mice. For all, bars represent mean ratio of phosphorylated:total protein
levels ± SEM.
(TIF)
S2 Fig. Overexpression of MsrA does not prevent oxidative damage in muscle of high fat
fed mice. Carbonyl levels in muscle from mice of indicated genotype and diet. Bars represent
average value for 3–5 animals; error indicated is standard deviation. Values are normalized to
average value for WT chow diet. Chow = chow diet. HFD = high fat diet. Significant effect of
diet, but no effect of genotype as measured by ANOVA.
(TIF)
S1 Supporting Information. Methods provided for carbonyl assay presented in S2 Fig.
(DOCX)
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